Boothbay Fund Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Boothbay Fund Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-123,414	Closed	-$2.3M	–	2905
2022 Q1	$2.3M	Buy	123,414 +112,844	+1,068%	+$2.03M	0.05%	522
2021 Q4	$226K	Sell	10,570 -56,306	-84%	-$1.11M	0.01%	1430
2021 Q3	$1.24M	Buy	+66,876	New	+$1.35M	0.03%	663

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's OCDX Position: Q2 2022 in Review

Boothbay Fund Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 123,414 shares — an estimated $2.3M sold.

Boothbay Fund Management first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $2.3M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Boothbay Fund Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 123,414 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.3M.
Boothbay Fund Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Boothbay Fund Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.3M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.